These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 25726316)

  • 1. Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma.
    Li SH; Chen CH; Lu HI; Huang WT; Tien WY; Lan YC; Lee CC; Chen YH; Huang HY; Chang AY; Lin WC
    Surgery; 2015 Mar; 157(3):570-80. PubMed ID: 25726316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation.
    Li SH; Lu HI; Chang AY; Huang WT; Lin WC; Lee CC; Tien WY; Lan YC; Tsai HT; Chen CH
    Oncotarget; 2016 Oct; 7(41):67150-67165. PubMed ID: 27564102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bufalin on the mTOR/p70S6K pathway and apoptosis in esophageal squamous cell carcinoma in nude mice.
    Liu Y; Wang X; Jia Y; Liu Y
    Int J Mol Med; 2017 Aug; 40(2):357-366. PubMed ID: 28656204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.
    Liu TT; Yang KX; Yu J; Cao YY; Ren JS; Hao JJ; Pan BQ; Ma S; Yang LY; Cai Y; Wang MR; Zhang Y
    J Mol Med (Berl); 2018 Aug; 96(8):807-817. PubMed ID: 29959473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of p70S6K Enhances Cell Sensitivity to Rapamycin in Esophageal Squamous Cell Carcinoma.
    Lu Z; Peng K; Wang N; Liu HM; Hou G
    J Immunol Res; 2016; 2016():7828916. PubMed ID: 27595116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR.
    Hou G; Xue L; Lu Z; Fan T; Tian F; Xue Y
    Cancer Lett; 2007 Aug; 253(2):236-48. PubMed ID: 17360108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of mTOR siRNA on mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cells and the growth of transplanted tumor in nude mice].
    Liu MY; Hou GQ; Zhang Y; Bei WJ; Yan AH
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):334-9. PubMed ID: 21875460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells.
    Bishop JD; Nien WL; Dauphinee SM; Too CK
    J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous activation of impaired autophagy and the mammalian target of rapamycin pathway in oral squamous cell carcinoma.
    Yin X; Hu L; Feng X; Wang H; Zhang C; Wang H; Wang S
    J Oral Pathol Med; 2019 Sep; 48(8):705-711. PubMed ID: 31132188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma.
    Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z
    Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
    Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma.
    Ma MC; Chiu TJ; Lu HI; Huang WT; Lo CM; Tien WY; Lan YC; Chen YY; Chen CH; Li SH
    J Cardiothorac Surg; 2018 Apr; 13(1):25. PubMed ID: 29636061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxiredoxin 1 promotes tumorigenesis through regulating the activity of mTOR/p70S6K pathway in esophageal squamous cell carcinoma.
    Gong F; Hou G; Liu H; Zhang M
    Med Oncol; 2015 Feb; 32(2):455. PubMed ID: 25579166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma.
    Wu N; Du Z; Zhu Y; Song Y; Pang L; Chen Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818758772. PubMed ID: 29463194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity of esophageal squamous cell carcinoma cells to rapamycin can be improved by siRNA-interfered expression of p70S6K].
    Liu M; Lu Z; Zheng Y; Cui Y; Wang J; Hou G
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):885-9. PubMed ID: 26887615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro.
    Li Q; Yang L; Han K; Zhu L; Zhang Y; Ma S; Zhang K; Yang B; Guan F
    Oncotarget; 2016 Sep; 7(38):61458-61468. PubMed ID: 27556183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance and function of mammalian target of rapamycin in tongue squamous cell carcinoma.
    Li SH; Chien CY; Huang WT; Luo SD; Su YY; Tien WY; Lan YC; Chen CH
    Sci Rep; 2017 Aug; 7(1):8178. PubMed ID: 28811537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
    Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
    Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic significance and function of mammalian target of rapamycin activation in esophageal squamous cell carcinoma.
    Kim SH; Chau GC; Jang YH; Lee SI; Pyo S; Um SH
    Hum Pathol; 2013 Feb; 44(2):226-36. PubMed ID: 22944293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.